Prediction of Alzheimer’s disease with serum lipid levels in Asian individuals: a meta-analysis

References

• Agarwal, R., et al., 2015. Effect of apolipoprotein E (APO E) polymorphism on leptin in Alzheimer's disease. Annals of Indian academy of neurology, 18 (3), 320–326.
   PubMed Web of Science ®Google Scholar
• Agirbasli, M., et al., 2015. Total cholesterol-to-high-density lipoprotein cholesterol ratio predicts high-sensitivity C-reactive protein levels in Turkish children. Journal of clinical lipidology, 9 (2), 195–200.
   PubMed Web of Science ®Google Scholar
• Alam, R., et al., 2014. Synergistic epistasis of paraoxonase 1 (rs662 and rs85460) and apolipoprotein E4 genes in pathogenesis of Alzheimer’s disease and vascular dementia. American journal of Alzheimer's disease & other dementias, 29, 769–776.
   PubMed Web of Science ®Google Scholar
• Anstey, K.J., Ashby-Mitchell, K., and Peters, R., 2017. Updating the evidence on the association between serum cholesterol and risk of late-life dementia: review and meta-analysis. Journal of Alzheimer's disease, 56 (1), 215–228.
   PubMed Web of Science ®Google Scholar
• Arvanitakis, Z., et al., 2016. Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study. Lancet neurology, 15 (9), 934–943.
   PubMed Web of Science ®Google Scholar
• Ban, Y., et al., 2009. Increased plasma urotensin-II and carotid atherosclerosis are associated with vascular dementia. Journal of atherosclerosis and thrombosis, 16 (3), 179–187.
   PubMed Web of Science ®Google Scholar
• Blasko, I., et al., 2011. Prospective study on association between plasma amyloid beta-42 and atherosclerotic risk factors. Journal of neural transmission, 118 (5), 663–672.
   PubMed Web of Science ®Google Scholar
• Breneman, C.B., et al., 2016. The impact of cardiorespiratory fitness levels on the risk of developing atherogenic dyslipidemia. American journal of medicine, 129 (10), 1060–1066.
   PubMed Web of Science ®Google Scholar
• Brookmeyer, R., et al., 2007. Forecasting the global burden of Alzheimer's disease. Alzheimer's & dementia, 3 (3), 186–191.
   PubMed Web of Science ®Google Scholar
• Burnham, S.C., et al., 2014. A blood-based predictor for neocortical Abeta burden in Alzheimer's disease: results from the AIBL study. Molecular psychiatry, 19 (4), 519–526.
   PubMed Web of Science ®Google Scholar
• Cankurtaran, M., et al., 2005. Are serum lipid and lipoprotein levels related to dementia? Archives of gerontology and geriatrics, 41 (1), 31–39.
   PubMed Web of Science ®Google Scholar
• Chandra, V. and Pandav, R., 1998. Gene-environment interaction in Alzheimer's disease: a potential role for cholesterol. Neuroepidemiology, 17 (5), 225–232.
   PubMed Web of Science ®Google Scholar
• Chang, L., et al., 2014. Elevation of peripheral BDNF promoter methylation links to the risk of Alzheimer's disease. PLoS one, 9 (11), e110773.
   PubMed Web of Science ®Google Scholar
• Chatterjee, P., et al., 2016. Plasma phospholipid and sphingolipid alterations in presenilin1 mutation carriers: a pilot study. Journal of Alzheimer's disease, 50 (3), 887–894.
   PubMed Web of Science ®Google Scholar
• Connor, W.E., et al., 1978. The plasma lipids, lipoproteins, and diet of the Tarahumara Indians of Mexico. The American journal of clinical nutrition, 31 (7), 1131–1142.
   PubMed Web of Science ®Google Scholar
• Duan, D. and Ling, Y.C., 2009. A clinical study on the serum triglyceride and total cholesterol of patients with vascular dementia and Alzheimer's disease. Chinese journal of prevention and control of chronic non-communicable diseases, 149–151.
   Google Scholar
• Emerson, S.R., et al., 2018. Postprandial metabolic responses differ by age group and physical activity level. The journal of nutrition, health & aging, 22 (1), 145–153.
   PubMed Web of Science ®Google Scholar
• Gandy, S., 2014. Alzheimer's disease: new data highlight nonneuronal cell types and the necessity for presymptomatic prevention strategies. Biological psychiatry, 75 (7), 553–557.
   PubMed Web of Science ®Google Scholar
• Granic, A. and Potter, H., 2013. Mitotic spindle defects and chromosome mis-segregation induced by LDL/cholesterol-implications for Niemann-Pick C1, Alzheimer's disease, and atherosclerosis. PLoS One, 8 (4), e60718.
   PubMed Web of Science ®Google Scholar
• Habchi, J., et al., 2018. Cholesterol catalyses Abeta42 aggregation through a heterogeneous nucleation pathway in the presence of lipid membranes. Nature chemistry, 10 (6), 673–683.
   PubMed Web of Science ®Google Scholar
• Haghighi, M., et al., 2015. Identifying cost-effective predictive rules of amyloid-β level by integrating neuropsychological tests and plasma-based markers. Journal of Alzheimer's disease, 43 (4), 1261–1270.
   PubMed Web of Science ®Google Scholar
• Han, J.F., 2005. Correlation between the levels of serum lipids and the onset of disease in patients with Alzheimer's disease. Chinese journal of clinical rehabilitation, 21 (9), 32–34.
   Google Scholar
• Higgins, J.P., et al., 2003. Measuring inconsistency in meta-analyses. BMJ (clinical research ed.), 327 (7414), 557–560.
   PubMed Web of Science ®Google Scholar
• Hoshino, T., Kamino, K., and Matsumoto, M., 2002. Gene dose effect of the APOE-epsilon4 allele on plasma HDL cholesterol level in patients with Alzheimer's disease. Neurobiology of aging, 23 (1), 41–45.
   PubMed Web of Science ®Google Scholar
• Kivipelto, M., et al., 2001. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ, 322, 1447–1451.
   PubMed Web of Science ®Google Scholar
• Ledesma, M.D. and Dotti, C.G., 2006. Amyloid excess in Alzheimer's disease: what is cholesterol to be blamed for? FEBS letters, 580 (23), 5525–5532.
   PubMed Web of Science ®Google Scholar
• Li, D., et al., 2018. Plasma lipoproteome in Alzheimer's disease: a proof-of-concept study. Clinical proteomics, 15, 31. DOI:10.1186/s12014-018-9207-z.
   PubMed Web of Science ®Google Scholar
• Li, G., et al., 2017. Effect of simvastatin on CSF Alzheimer disease biomarkers in cognitively normal adults. Neurology, 89 (12), 1251–1255.
   PubMed Web of Science ®Google Scholar
• Li, W., 2014. Relationship between changes of blood lipid metabolism and disease in patients with Alzheimer's disease. Medical information, 27 (11), 342–344.
   Google Scholar
• Liu, J.H. and Chen, Z.L., 2006. Observation of serum cholesterol IL-6 and VitB12 levels in Alzheimer’s disease or vascular dementia patients. Journal of Jiangsu University (medicine edition), 16 (1), 48–50.
   Google Scholar
• Liu, Z.S., 2005. Study of lipid metabolism in patients with sporadic Alzheimer's disease. Chinese journal of nervous and mental diseases, 31 (5), 383–387.
   Google Scholar
• Manoharan, S., et al., 2016. Alzheimer’s disease and medicinal plants: an overview. The benefits of natural products for neurodegenerative diseases. Cham: Springer International Publishing.
   Google Scholar
• Mapstone, M., et al., 2014. Plasma phospholipids identify antecedent memory impairment in older adults. Nature medicine, 20 (4), 415–418.
   PubMed Web of Science ®Google Scholar
• Matsuzaki, T., et al., 2011. Association of Alzheimer disease pathology with abnormal lipid metabolism: the Hisayama Study. Neurology, 77 (11), 1068–1075.
   PubMed Web of Science ®Google Scholar
• Nagga, K., et al., 2018. Increased midlife triglycerides predict brain beta-amyloid and tau pathology 20 years later. Neurology, 90, e73–e81.
   PubMed Web of Science ®Google Scholar
• Newton, W. and Mcmanus, A., 2011. Consumption of fish and Alzheimer's disease. The journal of nutrition, health & aging, 15 (7), 551.
   PubMed Web of Science ®Google Scholar
• Patsopoulos, N.A., Evangelou, E., and Ioannidis, J.P., 2008. Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. International journal of epidemiology, 37 (5), 1148–1157.
   PubMed Web of Science ®Google Scholar
• Prince, M., et al., 2016. World Alzheimer report 2016: improving healthcare for people living with dementia: coverage, quality and costs now and in the future. Available from: http://eprints.lse.ac.uk/id/eprint/67858.
   Google Scholar
• Raygani, A.V., et al., 2006. Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer's disease. Neuroscience letters, 408 (1), 68–72.
   PubMed Web of Science ®Google Scholar
• Reed, B., et al., 2014. Associations between serum cholesterol levels and cerebral amyloidosis. JAMA neurology, 71 (2), 195–200.
   PubMed Web of Science ®Google Scholar
• Reitz, C., 2013. Dyslipidemia and the risk of Alzheimer's disease. Current atherosclerosis reports, 15 (3), 307.
   PubMed Web of Science ®Google Scholar
• Reitz, C., et al., 2010. Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Archives of neurology, 67, 1491–1497.
   PubMedGoogle Scholar
• Schilling, S., et al., 2017. Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C study: a longitudinal, population-based prospective cohort study. PLoS medicine, 14 (3), e1002265.
   PubMed Web of Science ®Google Scholar
• Sery, O., et al., 2017. CD36 gene polymorphism is associated with Alzheimer's disease. Biochimie, 135, 46–53.
   PubMed Web of Science ®Google Scholar
• Shen, W.C., et al., 2017. The relationship between high-density lipoprotein cholesterol levels and arterial stiffness in a Taiwanese population. Nutrition, metabolism & cardiovascular diseases, 27 (12), 1136–1142.
   PubMed Web of Science ®Google Scholar
• Shim, Y.S., 2010. Elevated remnant lipoprotein cholesterol in patients with Alzheimer's disease and vascular dementia: a pilot study. Dementia and neurocognitive disorders, (9), 75–81.
   Google Scholar
• Shinohara, M., et al., 2017. Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies. Journal of lipid research, 58 (7), 1267–1281.
   PubMed Web of Science ®Google Scholar
• Singh, N.K., et al., 2012. Gene–environment interaction in Alzheimer’s disease. American journal of Alzheimer's disease & other dementias, 27, 496–503.
   PubMed Web of Science ®Google Scholar
• Sun, H., et al., 2002. Influence factors of human blood cholesterol level variation. Journal of Inner Mongolia university for nationalities, 17 (4), 334–338.
   Google Scholar
• Sun, X., et al., 2010. Analysis of correlation between insulin resistance, blood lipids and Alzheimer's disease. Journal of hygiene research, 39, 573–575.
   Google Scholar
• Sun, Y.L., 2006. Observation of blood lipid levels in patients with Alzheimer's disease. Chinese journal of misdiagnosis, 23 (6), 4543–4544.
   Google Scholar
• Vasantharekha, R., et al., 2017. Interrelationship between Mini-Mental State Examination scores and biochemical parameters in patients with mild cognitive impairment and Alzheimer's disease. Geriatrics & gerontology international, 17, 1737–1745.
   PubMed Web of Science ®Google Scholar
• Versmissen, J., et al., 2011. Apolipoprotein isoform E4 does not increase coronary heart disease risk in carriers of low-density lipoprotein receptor mutations. Circulation: cardiovascular genetics, 4 (6), 655–660.
   PubMedGoogle Scholar
• Wada, H., 2000. Analyses of serum concentrations of apolipoproteins in the demented elderly. Internal medicine (Tokyo, Japan), 39 (3), 220–222.
   PubMed Web of Science ®Google Scholar
• Wajman, J.R., Mansur, L.L., and Yassuda, M.S., 2018. Lifestyle patterns as a modifiable risk factor for late-life cognitive decline: a narrative review regarding dementia prevention. Current aging science, 11 (2). DOI:10.2174/1874609811666181003160225.
   PubMedGoogle Scholar
• Wang, C.Y., 2005. A clinical study of Alzheimer's disease and vascular dementia in serum cholesterol, Vit B12, and folate acid. Chinese journal of nervous & mental disease, 31 (3), 188–191.
   Google Scholar
• Wang, H., 2006. Study on the combining assay of total antioxidant status, high sensitive C-reactive protein and serum lipids in the diagnosis of Alzheimer's disease. Laboratory medicine, 21 (5), 465–467.
   Google Scholar
• Wang, R., et al., 2017. Plasma cystatin c and high-density lipoprotein are important biomarkers of Alzheimer’s disease and vascular dementia: a cross-sectional study. Frontiers in aging neuroscience, 9 (26). DOI:10.3389/fnagi.2017.00026.
   Web of Science ®Google Scholar
• Wang, X.H., 2016. Changes of serum levels of thyroid hormones and blood lipid in patients with varying degrees of Alzheimer's disease and related risk factors. Journal of clinical medicine in practice, 20 (5), 32–35.
   Google Scholar
• Watanabe, T., et al., 2004. Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia. Metabolism, 53 (4), 476–482.
   PubMed Web of Science ®Google Scholar
• Watanabe, T., et al., 2005. Relationship between serum insulin-like growth factor-1 levels and Alzheimer's disease and vascular dementia. Journal of the American geriatrics society, 53 (10), 1748–1753.
   PubMed Web of Science ®Google Scholar
• Wood, W.G., et al., 2014. Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis. Journal of neurochemistry, 129 (4), 559–572.
   PubMed Web of Science ®Google Scholar
• Xiao, Z., et al., 2012. Association studies of several cholesterol-related genes (ABCA1, CETP and LIPC) with serum lipids and risk of Alzheimer's disease. Lipids in health and disease, 11 (1), 163.
   PubMed Web of Science ®Google Scholar
• Yamamoto, H., et al., 2005. High prevalence of chlamydia pneumoniae antibodies and increased high-sensitive C-reactive protein in patients with vascular dementia. Journal of the American geriatrics society, 53 (4), 583–589.
   PubMed Web of Science ®Google Scholar
• Yanagisawa, K., 2002. Cholesterol and pathological processes in Alzheimer's disease. Journal of neuroscience research, 70 (3), 361–366.
   PubMed Web of Science ®Google Scholar
• Yang, C.Z., Tian, J.Z., and Zhong, J., 2007. Changes of blood lipid in mild cognitive impairment and Alzheimer's disease. Chinese journal of gerontology, 27 (6), 545–548.
   Google Scholar
• Yu, Z., et al., 2015. Relationship between adiponectin gene polymorphisms and late-onset Alzheimer's disease. PLoS one, 10 (4), e0125186.
   PubMed Web of Science ®Google Scholar
• Yuan, Y., et al., 2006. A study of serum lipid concentrations and apolipoprotein E genotype among patients with senile depression and Alzheimer disease. Chinese general practice, 9, 106–108.
   Google Scholar
• Yue, Y.H., 2009. Analysis of low density lipoprotein receptor-related protein gene 766C/T polymorphism and the levels of serum lipids in patients with Alzheimer's disease in Xinjiang Uygurs. Chinese journal of psychiatry, 42 (3), 129–133.
   Google Scholar
• Zarrouk, A., et al., 2018. Lipid biomarkers in Alzheimer's disease. Current Alzheimer research, 15 (4), 303–312.
   PubMed Web of Science ®Google Scholar
• Zengi, O., et al., 2012. Urinary 8-hydroxy-2′-deoxyguanosine level and plasma paraoxonase 1 activity with Alzheimer’s disease. Clinical chemistry and laboratory medicine, 50, 529–534.
   Web of Science ®Google Scholar
• Zhao, Z., et al., 2014. Expression and significance of plasma 3-NT and ox-LDL in patients with Alzheimer's disease. Genetics and molecular research, 13 (4), 8428–8435.
   PubMed Web of Science ®Google Scholar
• Zheng, J., et al., 2016a. The CYP19A1 rs3751592 variant confers susceptibility to Alzheimer disease in the Chinese Han population. Medicine, 95 (35), e4742.
   Web of Science ®Google Scholar
• Zheng, L., et al., 2016b. Association of apolipoprotein E (ApoE) polymorphism with Alzheimer's disease in Chinese population. Current Alzheimer research, 13 (8), 912–917.
   PubMed Web of Science ®Google Scholar
• Zhong, X., et al., 2016. Changes in serum homocysteine and its correlation with altitude, folacin and high-sensitivity C-reactive protein in Tihetan patients with mild-to-moderate Alzheimer's disease at different altitudes. Chinese journal of geriatrics, 35 (9), 934–938.
   Google Scholar
• Zhou, T.T., 2015. Comparative study on serum inflammatory cytokines and blood lipids in Alzheimer's disease and vascular dementia. Medical journal of Chinese people's health, 27 (11), 4–5.
   Google Scholar
• Zhu, J.Y., 2007. Comparison of serum lipids, serum CRP, Hcy and sIL-6R in patients with Alzheimer's disease and those of the same age. Practice geriatrics, 31 (3), 207–209.
   Google Scholar